Difference between revisions of "Talk:20.109(S17):Module 2"
From Course Wiki
(→T/R Western Blots) |
(→quantitative PCR data) |
||
| (7 intermediate revisions by one user not shown) | |||
| Line 1: | Line 1: | ||
{{Template:20.109(S17)}} | {{Template:20.109(S17)}} | ||
<div style="padding: 10px; width: 790px; border: 5px solid #6633CC;"> | <div style="padding: 10px; width: 790px; border: 5px solid #6633CC;"> | ||
| + | |||
| + | ==References from Prof. Samson Lecture 8== | ||
| + | *[[Media:Thermo BRCA2 cell line .pdf| A syngeneic variance library for functional annotation of human variation: application to ''BRCA2''.]] | ||
| + | *[[Media:Adachi et al BioChem 2003.pdf| Hypersensitivity of Nonhomologous DNA End-joining Mutants to VP-16 and ICRF-193.]] | ||
| + | *[[Media:Engineered BRCA2mutations Invitrogen.pdf| Compound screening in BRCA2 (–/–) GeneArt Engineered Cell Model.]] | ||
| + | *[[Media:Lin et al PLOS 2009.pdf| p63 and p73 Transcriptionally Regulate Genes Involved in DNA Repair.]] | ||
| + | *[[Media:Nagel et al PNAS 2014.pdf| Multiplexed DNA repair assays for multiple lesions and multiple doses via transcription inhibition and transcriptional mutagenesis.]] | ||
| + | *[[Media:Treszezamsky et al CanRes 2007.pdf| BRCA1- and BRCA2-Deficient Cells Are Sensitive to Etoposide-Induced DNA Double-Strand Breaks via Topoisomerase II.]] | ||
| + | |||
| + | ==quantitative PCR data== | ||
| + | [[Media:20.109 Spring 2017, M2 qPCR results v2.xlsx|qPCR data ]] | ||
==CellTiter Glo luminescence cell viability assay== | ==CellTiter Glo luminescence cell viability assay== | ||
| Line 24: | Line 35: | ||
===W/F Western Blots=== | ===W/F Western Blots=== | ||
| + | [[Image:Sp17_Mod2_WFgel1_700.jpg |thumb|left|400px| Red, Yellow, Green samples]] | ||
| + | [[Image:Sp17_Mod2_WFgel2_700.jpg |thumb|left|400px| Blue, Pink Purple samples]] | ||
| + | |||
| + | <br style="clear:both;"/> | ||
Latest revision as of 19:41, 13 April 2017
Contents
References from Prof. Samson Lecture 8
- A syngeneic variance library for functional annotation of human variation: application to BRCA2.
- Hypersensitivity of Nonhomologous DNA End-joining Mutants to VP-16 and ICRF-193.
- Compound screening in BRCA2 (–/–) GeneArt Engineered Cell Model.
- p63 and p73 Transcriptionally Regulate Genes Involved in DNA Repair.
- Multiplexed DNA repair assays for multiple lesions and multiple doses via transcription inhibition and transcriptional mutagenesis.
- BRCA1- and BRCA2-Deficient Cells Are Sensitive to Etoposide-Induced DNA Double-Strand Breaks via Topoisomerase II.
quantitative PCR data
CellTiter Glo luminescence cell viability assay
Western blot images
Instructor's Western Blot
T/R Western Blots
W/F Western Blots
